Valuation: DiaSorin S.p.A.

Market Cap 3.98B 4.45B 3.65B 3.32B 6.23B 422B 6.39B 43.6B 17.54B 223B 16.71B 16.35B 705B P/E 2026 *
24.3x
P/E 2027 * 20.8x
Enterprise Value 4.67B 5.23B 4.29B 3.9B 7.32B 495B 7.5B 51.22B 20.6B 261B 19.62B 19.21B 829B EV / Sales 2026 *
3.78x
EV / Sales 2027 * 3.45x
Free-Float
37.17%
Yield 2026 *
1.61%
Yield 2027 * 1.68%
1 day+0.07%
1 week-0.37%
Current month-0.20%
1 month+5.90%
3 months+6.97%
6 months+35.13%
Current year+17.17%
1 week 79.42
Extreme 79.42
81.98
1 month 74.72
Extreme 74.72
82.3
Current year 52.34
Extreme 52.34
82.3
1 year 52.34
Extreme 52.34
82.3
3 years 52.34
Extreme 52.34
112.35
5 years 52.34
Extreme 52.34
196.25
10 years 49.98
Extreme 49.98
211.8
Manager TitleAgeSince
Chief Executive Officer 60 26/03/2007
Director of Finance/CFO - 01/01/2025
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 60 28/04/2016
Director/Board Member 63 26/03/2007
Chairman 57 29/04/2022
Date Insider Type Main position Quantity % Market Cap. Importance
24/3/26 Buy

Chief Executive Officer

9,211 0.0165%
28/1/26 Buy

Chief Executive Officer

7,500 0.0134%
8/1/26 Buy

Director

700 0.0013%
Change 5-day change 1-year change 3-year change Capi.($)
+0.07%-0.37%+5.40%-10.90% 4.45B
-0.68%+6.14%-11.64%+14.18% 191B
-0.54%+5.12%+9.49%+36.11% 122B
+0.89%+2.66%-13.60%+12.03% 117B
-1.42%+1.35%-41.88%+5.74% 96.21B
+0.43%+4.07%-0.68%+73.49% 64.47B
-5.48%-5.11%-1.24%+61.88% 52.51B
-0.58%+1.50%+11.65%-23.54% 54.1B
+0.61%+20.51%-6.44%+57.55% 52.91B
-0.96%+3.92%+1.49%-10.71% 35.65B
Average -0.77%+3.41%-4.74%+21.58% 78.93B
Weighted average by Cap. -0.67%+3.92%-8.14%+23.28%

Financials

2026 *2027 *
Net sales 1.24B 1.38B 1.13B 1.03B 1.94B 131B 1.98B 13.54B 5.45B 69.12B 5.19B 5.08B 219B 1.31B 1.47B 1.21B 1.1B 2.06B 139B 2.11B 14.41B 5.8B 73.54B 5.52B 5.4B 233B
Net income 181M 203M 166M 151M 284M 19.2B 291M 1.99B 799M 10.14B 761M 745M 32.13B 205M 229M 188M 171M 320M 21.69B 329M 2.24B 902M 11.45B 859M 841M 36.28B
Net Debt 694M 777M 638M 579M 1.09B 73.62B 1.12B 7.61B 3.06B 38.86B 2.92B 2.85B 123B 556M 622M 510M 463M 870M 58.9B 892M 6.09B 2.45B 31.09B 2.33B 2.28B 98.54B
Projected Income Statement - Annual - DiaSorin S.p.A.
Logo DiaSorin S.p.A.
DiaSorin SpA is an Italy-based company engaged in healthcare industry. The Company specializes in provision of developing, producing and commercializing reagent kits for the in vitro diagnostics. The Company develops and manufactures reagents for in vitro diagnostics and produces products for the fields of infectious disease, hepatitis, endocrinology, bone & mineral metabolism, cancer, brain injury, cardiac, therapeutic drug monitoring and autoimmunity. The Company’s business activities are divided into two markets. The Immunodiagnostics market develops, produces and markets immunoreagent kits, which are based on three techniques: Chemiluminescence (CLIA), Colorimetry (ELISA) and Radioimmunometry (RIA). The Molecular Diagnostics market supplies end laboratories with an automated result to perform the three steps for the final diagnostic result, including nucleic acids extraction, amplification and diagnosis. It operates through ELISA immunodiagnostic business portfolio.
Employees
3,260
Date Price Change Volume
04/11/26 EUR 80.40 +0.07% 66,669
02/11/26 EUR 80.34 -0.27% 87,481
30/10/26 EUR 80.56 -0.05% 92,271
29/10/26 EUR 80.60 -1.42% 115,226
28/10/26 EUR 81.76 +1.31% 119,964
Trader
Investor
Global
Quality
ESG MSCI
BBB
MarketScreener Ratings - DiaSorin S.p.A.
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
80.34EUR
Average target price
76.38EUR
Spread / Average Target
-4.93%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - DiaSorin S.p.A.